Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
29th European Committee for Treatment and Research in Multiple Sclerosis Congress
Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.
Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis.
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
Clinical Characteristics of Pediatric-Onset and Adult-Onset Multiple Sclerosis in Hispanic Americans.
GlaxoSmithKline Product Development Pipeline
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
The quality of reports of randomized trials in multiple sclerosis: a review.
215ON201 BIIB033 In Acute Optic Neuritis (AON) (RENEW)
Episode 8 with Dr. Wendy Macklin on myelination and the zebrafish model of MS
TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab.
Episode 35 with Dr. Daniel Reich on neuroradiology in MS
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Episode 31 with Dr. Lloyd Kasper on the gut microbiome and MS
Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
The Fourth International Conference on Regulatory T Cells and TH Subsets and Clinical Applications in Human Disease
Mechanism of action of mitoxantrone.
NYSCF Webinar Series: Multiple Sclerosis and the Promise of Stem Cell Research
Genes associated with T helper 17 cell differentiation and function.
XI European Meeting on Glia Cells in Health and Disease
Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis.
Place of birth, age of immigration, and disability in Hispanics with multiple sclerosis.
Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies.
Long-term efficacy and safety of transanal irrigation in multiple sclerosis.
Pages
« first
‹ previous
…
56
57
58
59
60
61
62
63
64
…
next ›
last »